𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia

✍ Scribed by S. Pavlovsky; J. Gonzalez Llaven; M. A. Garcia Martinez; P. Sobrevilla; M. Eppinger-Helft; A. Marin; M. López-Hernández; I. Fernandez; M. E. Rubio; S. Ibarra; M. Lluesma; G. Ruiz Arguelles; F. José de Diego

Publisher
Springer
Year
1994
Tongue
English
Weight
444 KB
Volume
69
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of continuous infusio
A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia
✍ Yener Koc; Basak Oyan; Ayse Kars; Gulten Tekuzman; Hande Canpinar; Emin Kansu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

## Abstract Mitoxantrone (MTZ) has been shown to be effective in the treatment of newly diagnosed acute myeloblastic leukemia (AML). The objective of this randomized study was to evaluate the impact of mode of administration of MTZ on the response and recurrence rates in newly diagnosed patients wi

A Phase I–II trial of escalating doses o
A Phase I–II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia
✍ Charles A. Koller; Hagop M. Kantarjian; Eric J. Feldman; Susan O'Brien; Mary Bet 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## BACKGROUND. Cytarabine is an essential drug for inducing remission of acute myelogenous leukemia, and it is also one the most effective drugs used as salvage therapy for patients with all types of relapsed acute leukemia. Nevertheless, there is considerable room for improvement in the treatment

A scoring system to predict the risk of
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia
✍ David Valcárcel; Pau Montesinos; Isabel Sánchez-Ortega; Salut Brunet; Jordi Este 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou

Lineage specific treatment of adult pati
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine : Cancer and Leukemia Group B Study 9311
✍ Ted P. Szatrowski; Richard K. Dodge; Carol Reynolds; Carol A. Westbrook; Stanley 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Background: Anti-b4-blocked ricin is an immunotoxin comprised of an anti-cd19 murine monoclonal antibody (b4) conjugated to blocked ricin, which has cytotoxic activity in patients with lymphoid malignancies. ## Methods: Adults with untreated acute lymphoblastic leukemia (all) were treated with